90. Retinitis pigmentosa
103 clinical trials,   158 drugs   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways

Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2012-002436-82-ES
(EUCTR)
13/12/201222/10/2012Melatonin effects on visual and sleep patterns anomalies in subjects diagnosed with Retinitis PigmentosaMelatonin effects on visual and sleep patterns anomalies in subjects diagnosed with Retinitis Pigmentosa To evaluate the sleep quality in patients with Retinitis Pigmentosa;Therapeutic area: Diseases [C] - Eye Diseases [C11]Trade Name: CIRCADIN 2 mg comprimidos de liberación prolongada
Product Name: Circadin 2 mg
INN or Proposed INN: Not answered
Other descriptive name: MELATONIN
Isabel Pinilla LozanoNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Spain